Evidence map›Paper›PMID 28396612›Full record

SynthesisDisease markers2017

Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Lingling He, Xiaoli Liu, Yalin Zhao, Shuan Zhang, Yuyong Jiang, Xianbo Wang, Zhiyun Yang

Open access · hybridAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Disease markers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Current Therapy of Chronic Viral Hepatitis B, C and D.Journal of personalized medicine · 2023
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lingling HeCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xiaoli LiuCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yalin ZhaoCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Shuan ZhangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yuyong JiangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xianbo WangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Zhiyun YangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; Collaborative Innovation Center of Infectious Diseases, Capital Medical University, Chaoyang, Beijing 10015, China.ORCID 0000-0002-1522-0749
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenineAntiviral AgentsArabinofuranosyluracilCarcinoma, HepatocellularGuanineHepatitis B, ChronicHepatitis B virusHumansLamivudineLiver NeoplasmsOrganophosphonatesRetrospective StudiesSurvival AnalysisTelbivudineTenofovirThymidineadefovirAdenineAntiviral AgentsArabinofuranosyluracilclevudineentecavirGuanineLamivudineOrganophosphonatesTelbivudineTenofovirThymidine

Identifiers

PMID28396612
PMCPMC5370486
OpenAlexW2603090334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.